BRAF and thyroid gland carcinoma: In addition, patients carrying the BRAF mutation are having lower CD8 T cells % (p-value: 4.00e-7) and higher Treg cell % (p-value: 6.64e-12), which is consistent with another study of human thyroid cancer.